Zobrazeno 1 - 10
of 145
pro vyhledávání: '"M. E. Bertrand"'
Autor:
C, Bauters, C, Amant, A, Boullier, P, Cabrol, E, McFadden, P, Duriez, M E, Bertrand, P, Amouyel, A, Boulier
Publikováno v:
Circulation. 101:740-743
Background —Oxidation of LDL plays a role in endothelial dysfunction. Paraoxonase, an enzyme present on HDL, protects LDL against oxidation. Paraoxonase activity is genetically determined in part, and 3 genotypes have been described with variable e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::15c2c48f6e9d628060e05569121060d6
https://doi.org/10.1161/01.cir.101.7.740
https://doi.org/10.1161/01.cir.101.7.740
Publikováno v:
Trends in cardiovascular medicine. 7(3)
Restenosis remains the major limitation of percutaneous transluminal coronary angioplasty. Restenosis after balloon angioplasty is due to vascular remodeling and neointimal hyperplasia. In spite of encouraging results in animal models, most of the ph
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::6170626533bad1faa565954c0dd378fa
https://pubmed.ncbi.nlm.nih.gov/21235870
https://pubmed.ncbi.nlm.nih.gov/21235870
Autor:
Lars Wallentin, Alexander G.G. Turpie, Richard C. Becker, R. Conti, Freek W.A. Verheugt, W.S. Hillis, Werner Klein, Christoph Bode, M. E. Bertrand, D.D. Waters, Attilio Maseri, James H. Chesebro, John G.F. Cleland
Publikováno v:
Clinical Cardiology, 22, 551-553
Clinical Cardiology, 22, pp. 551-553
Clinical Cardiology, 22, pp. 551-553
Unstable coronary artery disease continues to pose a major challenge to clinicians. The advent of new therapies, such as percutaneous transluminal coronary angioplasty, low-molecular-weight heparins, and glycoprotein IIb/IIIa inhibitors, provides new
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::839204255e8fab06d9e3bc297f454206
https://hdl.handle.net/2066/186085
https://hdl.handle.net/2066/186085
Autor:
M E, Bertrand, M L, Simoons, K A, Fox, L C, Wallentin, C W, Hamm, E, McFadden, P J, de Feyter, G, Specchia, W, Ruzyllo
Publikováno v:
European heart journal. 21(17)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::6e2152709d4294a3ea67b3f9c14f9c1f
https://pubmed.ncbi.nlm.nih.gov/11465971
https://pubmed.ncbi.nlm.nih.gov/11465971
Autor:
M C, Vrolix, V M, Legrand, J H, Reiber, G, Grollier, M J, Schalij, P, Brunel, L, Martinez-Elbal, M, Gomez-Recio, F W, Bär, M E, Bertrand, A, Colombo, J, Brachman
Publikováno v:
The American journal of cardiology. 86(4)
The purpose of this study was to determine the feasibility, safety, and efficacy of elective stenting with heparin-coated Wiktor stents in patients with coronary artery disease. In experimental studies, heparin coating has been shown to prevent subac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::db61a977e58b987e198d061f0a95c5ca
https://pubmed.ncbi.nlm.nih.gov/11417538
https://pubmed.ncbi.nlm.nih.gov/11417538
Autor:
W E, Boden, W H, van Gilst, R G, Scheldewaert, I R, Starkey, M F, Carlier, D G, Julian, A, Whitehead, M E, Bertrand, J J, Col, O L, Pedersen, K I, Lie, J P, Santoni, K M, Fox
Publikováno v:
Lancet (London, England). 355(9217)
Diltiazem reduces non-fatal reinfarction and refractory ischaemia after non-Q-wave myocardial infarction, an acute coronary syndrome similar to the incomplete infarction that occurs after successful reperfusion. We postulated that this agent would re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::2259d6a97719b711f689a5e47141f4d4
https://pubmed.ncbi.nlm.nih.gov/11075793
https://pubmed.ncbi.nlm.nih.gov/11075793
Publikováno v:
Seminars in interventional cardiology : SIIC. 4(3)
In humans, circulating levels of angiotensin-converting enzyme (ACE) are linked with an insertion (I)/deletion (D) polymorphism in the ACE gene: DD genotype bearers have higher levels of ACE than either ID or II genotype bearers. Recent studies have
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::7394f77ba3cd257154ea2871ce38f816
https://pubmed.ncbi.nlm.nih.gov/10545620
https://pubmed.ncbi.nlm.nih.gov/10545620
Autor:
F W, Verheugt, R C, Becker, M E, Bertrand, C, Bode, J H, Chesebro, J G, Cleland, R, Conti, W S, Hillis, W, Klein, A, Maseri, A G, Turpie, L, Wallentin, D D, Waters
Publikováno v:
Clinical cardiology. 22(9)
Unstable coronary artery disease continues to pose a major challenge to clinicians. The advent of new therapies, such as percutaneous transluminal coronary angioplasty, low‐molecular‐weight heparins, and glycoprotein IIb/IIIa inhibitors, provides
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::c77234bc2ca18584e1c2822b2cacbe8b
https://pubmed.ncbi.nlm.nih.gov/10486693
https://pubmed.ncbi.nlm.nih.gov/10486693
Publikováno v:
European heart journal. 19
Angiotensin-converting enzyme (ACE) inhibitors have an accepted place in the treatment of hypertension and heart failure. However, at present they have no specific role in the prevention or treatment of coronary artery disease: evidence from animal e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::9b5d1747555252c0c0ac6de400b46a8d
https://pubmed.ncbi.nlm.nih.gov/9796841
https://pubmed.ncbi.nlm.nih.gov/9796841
Autor:
J M, Lablanche, E P, McFadden, N, Meneveau, J R, Lusson, B, Bertrand, J P, Metzger, V, Legrand, G, Grollier, C, Macaya, B, de Bruyne, A, Vahanian, A, Grentzinger, C, Masquet, J E, Wolf, G, Tobelem, S, Fontecave, A, Vacheron, P, d'Azemar, M E, Bertrand
Publikováno v:
Circulation. 96(10)
Experimental studies suggest that the antiproliferative effect of heparin after arterial injury is maximized by pretreatment. No previous studies of restenosis have used a pretreatment strategy. We designed this study to determine whether treatment w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::9f01ab167613eebb2566276fde68c2f5
https://pubmed.ncbi.nlm.nih.gov/9396433
https://pubmed.ncbi.nlm.nih.gov/9396433